Stocks and Shares
The latest news, updates and opinions on Stocks and Shares from the expert team here at MoneyWeek
Explore Stocks and Shares
-
The most likely outcome of the AI boom is a big fall
Opinion Like the dotcom boom of the late 1990s, AI is not paying off – despite huge investments being made in the hope of creating AI-based wealth
By Bill Bonner Published
Opinion -
What we can learn from Britain’s "Dashing Dozen" stocks
Stocks that consistently outperform the market are clearly doing something right. What can we learn from the UK's top performers and which ones are still buys?
By Dr Mike Tubbs Published
-
The rise of Robin Zeng: China’s billionaire battery king
Robin Zeng, a pioneer in EV batteries, is vying with Li Ka-shing for the title of Hong Kong’s richest person. He is typical of a new kind of tycoon in China
By Jane Lewis Published
-
Europe's forgotten equities offer value and growth
Opinion Jonathon Regis, co-portfolio manager, Developed Markets UCITS Strategy, Lansdowne Partners, highlights forgotten equities he'd put his money in
By Jonathon Regis Published
Opinion -
How retail investors can gain exposure to Lloyd’s of London
It’s hard for retail investors to get in on the action at Lloyd’s of London. Here are some of the ways to gain exposure
By Rupert Hargreaves Published
-
The flaw in Terry Smith’s strategy at Fundsmith
Opinion Fundsmith has invested in some excellent companies, but it has struggled to decide when to sell, says Max King
By Max King Published
Opinion -
The goal of business is not profit, but virtue
Opinion Serve your customers well, and the profits will follow, according to a new book. It rarely works the other way around, says Stuart Watkins
By Stuart Watkins Published
Opinion -
Picton Property: a deep-value property play
Picton Property has all the qualities of a future takeover target
By Rupert Hargreaves Published
-
How to invest in the travel industry's boom
The travel industry is in rude health despite uncertainty about the global economy, Trump’s policies and geopolitical concerns. Investors should buy in now
By Dr Matthew Partridge Published